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The impact of an enhanced recovery after surgery (ERAS) programme in emergency colorectal surgery 
has not yet been reported. The objective of this study was to evaluate the feasibility and the results of 
patients included in an ERAS protocol following emergency colon surgery for left colon perforation. 
For this purpose, patients with a low to moderate risk of mortality, according to a Peritonitis Severity 
Score (PSS), and treated with an ERAS protocol (ERAS group) after emergency surgery for left colon 
perforation were compared for a period of 40 months (March 2014–June 2017) with a control group of 
patients treated with conventional care (CC group) during the 38 months prior to implementation of 
the new ERAS protocol (January 2011–February 2014). The main endpoint was 90-day postoperative 
morbidity according to the Clavien–Dindo classification. Secondary endpoints included length of 
postoperative hospital stay, 90-day readmission rate, protocol compliance and mortality. Fifty patients 
were included in the study, 29 in the ERAS group and 21 in the CC group. There were no significant 
differences between the groups in the demographic data or in the operative characteristics. A reduction 
in the incidence of postoperative complications (20.7% vs. 38%; p > 0.05) and in the postoperative 
hospital stay (7.7 + /- 3.85 vs. 10.9 + /- 5.6 days; p = 0.009) were observed in the ERAS group. The 90-
day readmission rate did not differ significantly between the two groups (2 vs. 1). No 90-day mortality 
was observed in either group. The ERAS group showed better results than the CC group in protocol 
compliance. We conclude that ERAS protocols are feasible and help to reduce morbidity and length of 
hospital stay without adversely affecting the rate of readmission or mortality.
Enhanced recovery after surgery (ERAS) programmes in elective colorectal surgery are widespread and broadly 
accepted. The results of several multicentre studies1,2, controlled and randomised trials3, and corresponding 
meta-analyses4,5 have shown significant reductions in morbidity and postoperative hospital stays when applying 
these programmes compared to outcomes when applying conventional perioperative care in patients undergoing 
elective colorectal surgery.
As of 2008, the interdisciplinary GERM1 (Spanish Multimodal Rehabilitation Group) team has applied ERAS 
guidelines to patients undergoing surgical procedures for colon resection, with extensions to other elective gas-
trointestinal surgical procedures. The Spanish Ministry of Health recently published6 the clinical pathway for 
enhanced recovery in elective abdominal surgery (RICA) with the aim of homogenising and standardising all 
related procedures and processes.
However, things are different in emergency situations. Due to the complexity of individual patients and their 
management, application of the ERAS guidelines to patients undergoing emergency colon surgery has not been 
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widespread. Some authors7–11 have reported that the preliminary results of these programmes demonstrate their 
viability and effectiveness for this type of surgical patient.
One condition requiring emergency surgery is perforation of the left colon, which is often secondary to acute 
diverticulitis, with other less frequent causes including tumour, iatrogenic sources, ischaemia and perforation by 
foreign body12. These patients are vulnerable to sepsis secondary to perforation and subsequent peritonitis. The 
severity of a patient’s condition and the operative risk (which contribute to the patient’s prognosis and selection of 
the appropriate surgical procedure) vary. Prognostic scales based on objective results, such as the PSS classifica-
tion (Peritonitis Severity Score)13, facilitate appropriate management of each situation and patient.
Based on previous experience gained since 2009 and on the management of a multimodal rehabilitation guide 
applicable to patients submitted to elective colorectal surgery1,2, in 2014 GERM proposed new ERAS guidelines 
for the management of patients undergoing emergency colon surgery. To the best of our knowledge, this is the 
first published study on the applicability and results of a specific ERAS protocol in the management of patients 
with left colon perforation requiring emergency colon surgery.
Methods
The study was designed as a two-centre prospective study controlled with a retrospective group.
A consecutive series of patients (the ERAS group) from the General Hospital of Igualada (Barcelona) and 
the University Hospital of Elche (Alicante)—both of which are GERM members—who underwent emergency 
surgery with a diagnosis of left colon perforation received perioperative care according to the ERAS protocol 
between March 2014 and June 2017. This new specific protocol adapted by the GERM team is shown in Tables 1 
and 2.
The matched control group received conventional perioperative care (the CC group). Controls were identified 
by searching an electronic database for consecutive patients who underwent surgery in our hospitals between 
January 2011 and February 2014 (before introduction of the ERAS programme) and met the inclusion and exclu-
sion criteria for ERAS.
The inclusion criteria were patients aged over 18 years with a low to moderate risk of mortality according to 
a Peritonitis Severity Score (PSS; between 6 and 11 points). The exclusion criteria were patients aged less than 18 
years and those with a high risk of mortality according to the PSS (12 points or higher).
The main endpoint was 90-day postoperative morbidity according to the Clavien–Dindo classification. The 
secondary endpoints were length of postoperative hospital stay, 90-day readmission rate, protocol compliance 
and mortality.
Preoperative
• Antibiotic and thromboembolic prophylaxis (as per the hospital 
protocol)
• Blood glucose control
• C-reactive protein
• Stoma marking
• No anaesthetic premedication
Intraoperative
Anaesthetic procedure
• Nausea and vomiting prophylaxis: dexamethasone (5 mg) and 
ondansetron (4 mg)
• Epidural catheter for analgesia (T6−T10 according to incision): 
levobupivacaine 0.125−0.0675%.
• Basic ASA.
• Non-invasive blood pressure, pulse oximetry, heart rate.
• Hypothermia prevention (thermal blanket 37 °C).
• Optimisation of fluid therapy with Doppler monitoring whenever 
possible.
• Intravenous fluid balance: fluid therapy with continuous infusion of 
balanced solution (3.5 ml/kg/h for laparoscopic surgery and 7 ml/kg/h 
for laparotomy).
• Invasive monitoring if necessary (central line, arterial catheter) to 
avoid central intravenous catheters.
• Maintenance of anaesthesia with total intravenous anaesthesia.
• Infiltration of local anaesthetic into the incision and trocar sites.
• Avoid opiates (use short-acting opioids if needed).
• Maintain blood haemoglobin levels above 8 g/dL.
Surgical procedure
• Laparoscopy or laparotomy.
• Avoid abdominal drains.
• Nasogastric aspiration, if present, will be removed before extubation 
or within <12 postoperative hours.
Table 1. Preoperative and intraoperative ERAS protocol for emergency colon surgery.
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The preoperative variables analysed were sex, age, perforation aetiology, antibiotic prophylaxis, glycaemic 
control, CPR determination, stoma marking, and premedication. The intraoperative variables analysed were ASA 
(American Society of Anaesthesiologists) classification, nausea and vomiting prophylaxis, epidural analgesia, 
hypothermia prevention, fluid optimisation (monitoring), opiate use, surgical procedure performed, access to the 
abdominal cavity (laparotomy or laparoscopy) and PSS. The postoperative variables analysed were removal of the 
nasogastric tube (NGT) before 12 hours, active mobilisation of the patient, oral intake before 24 hours, removal of 
abdominal drainage tubes before 48 hours, removal of intravenous and urinary catheters at 48 hours, CPR levels, 
complications, prognosis according to the Clavien–Dindo classification14, mortality, length of hospital stay and 
postoperative readmissions within 90 days. Protocol compliance in the ERAS group was also analysed. The data 
were recorded using Microsoft Office ® Excel software, and the analysis was conducted using SPSS ® software.
Independence between qualitative variables was checked using the chi-square test or Fisher’s exact test, which 
was used when the chi-square test assumptions were not met. Independence between quantitative variables was 
checked using Student’s t-test or Mann–Whitney U test, which was used when normality assumptions were not 
met.
This study was carried out in accordance with the Helsinki Declaration and approved by the Ethics Committee 
of the Elche University Hospital. Patients in the ERAS group gave written informed consent before the study. 
Informed consent of the control group was waived by the approving ethics committee.
Results
A total of 50 patients were included in the study: 29 in the ERAS Group and 21 in the CC group.
No significant differences between the ERAS group and the CC Group were observed in the patients’ demo-
graphic data or in the operative characteristics (sex, age, aetiology of colonic perforation, surgical procedure 
performed, access to the abdominal cavity (laparotomy or laparoscopy) and PSS) (see Table 3).
No significant differences in compliance were found for four of the preoperative items analysed (antibiotic 
prophylaxis, thromboembolic prophylaxis, glycaemic control, and premedication), although significant differ-
ences were found for C-reactive protein determination (ERAS 24/29 vs. CC 7/21) and stoma marking (ERAS 
10/29 vs. CC 0/21; p < 0.05) in the ERAS group (see Table 4).
No significant differences in compliance were found for six of the intra-operative items analysed (epidural 
analgesia, hypothermia prevention, laparoscopic colon resection, laparoscopic lavage + drainage, overall lap-
aroscopy access and abdominal drains), although significant differences were found for nausea and vomiting 
prophylaxis (ERAS 18/29 vs. CC 6/21), monitored fluid optimisation (ERAS 11/29 vs. CC 0/21) and opiate use 
(ERAS 19/29 vs. CC 4/21; p < 0.05) in the ERAS group (see Table 4).
Significant differences were found for all postoperative items in the ERAS group, including removal of the 
nasogastric tube before 12 postoperative hours (ERAS 23/29 vs. CC 0/2), mobilisation before 24 postoperative 
hours (ERAS 23/29 vs. CC 0/21), oral intake before 24 postoperative hours (ERAS 26/29 vs. CC 0/2), abdominal 
PO 
Day Diet Medication Mobilisation
Removal of 
tubes
Blood 
Tests
0
Start fluid intake 
after 20 to 24 PO 
hours
Analgesia
Paracetamol 1 g IV/8 h. 
(alternate)
Dexketoprofen 50 mg 
IV/8 h. (alternate)
Omeprazole 20 mg 
IV/24 h
Antibiotics as per 
protocol
Enoxaparin 40 mg 
Sc/24 h
Start sedestation
1
Progressive diet 
according to 
tolerance
Same SedestationStart ambulation
2
• Progressive 
diet according to 
tolerance
• Stop IV fluid 
therapy if 
tolerated.
• Maintain 
heparinised IV
If diet is tolerated:
• Analgesia:
Paracetamol 1 g oral/8 h
Ibuprofen 600 mg 
oral/8 h (alternate)
• Omeprazole 20 mg 
oral/24 h
• Antibiotics as per 
protocol
• Enoxaparin 40 mg 
Sc/24 h
Equal
• Removal 
of epidural 
analgesia
• Removal of 
bladder catheter
• Removal of 
abdominal 
drainage
3 Basal diet Same Same With CRP
4/5 Basal diet Same Same CPR (5 days)
6 Basal diet
Discharge criteria: 
No complications, 
controlled pain, 
complete ambulation, 
patient acceptance.
Table 2. Postoperative ERAS programme for emergency colon surgery.
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ERAS 
group 
(n = 29)
CC group 
(n = 21)
Statistical 
significance 
p < 0.05
Sex (M = male, 
F = female) 21 M/8 F 17 M/4 F N/S
Age (mean ± standard 
deviation) 54 ± 3,08 58 ± 2,87 N/S
Aetiology
• Acute diverticulitis 
(AD) 24 17 N/S
• Neoplasm (N) 2 1 N/S
• Iatrogenic (Y) 2 3 N/S
• Ischaemia (I) 1 0 N/S
Surgical intervention
• Resection and 
anastomosis (RA) 11 10 N/S
• Hartmann (HP) 13 7 N/S
• Lavage and drainage 
(LD) 3 2 N/S
• Simple suture (SS) 2 2 N/S
PSS score 
(mean ± standard 
deviation)
7.7 ± 2.5
Table 3. Demographic data and operative characteristics for patients in the ERAS group versus the 
conventional care (CC) group.
Items
ERAS 
group 
(n = 29)
ERAS group 
compliance 
(%)
CC 
group 
(n = 21)
CC group 
compliance 
(%)
Statistical 
significance 
p < 0.05
Preoperative items
Antibiotic prophylaxis 29/29 100% 21/21 100% N/S
Thromboembolic prophylaxis 29/29 100% 21/21 100% N/S
Glycaemia control 29/29 100% 21/21 100% N/S
Determination of C-reactive 
protein 24/29 82.7% 7/21 33% <0.01
Stoma marking 10/29 34.4% 0/21 0% 0.003
No anaesthesic premedication 29/29 100% 21/21 100% N/S
Intraoperative items
Nausea and vomiting 
prophylaxis 18/29 62% 6/21 28.5% 0.04
Epidural analgesia 11/29 38% 7/21 33% N/S
Hypothermia prevention 6/29 20.6% 2/21 9.52% N/S
Fluid optimisation (monitoring) 11/29 38% 0/21 0% 0.001
No opiates 19/29 65.5% 4/21 19.5% 0.003
Laparoscopic colon resection 4/29 13.7% 0/21 0% N/S
Lavage + drainage via 
laparoscopy 3/29 10.3% 2/21 9.52% N/S
Total laparoscopic access 7/29 24% 2/21 9.52% N/S
No abdominal drains 3/29 10.3% 1/21 4.76% N/S
Postoperative items
NGT removal within 12 PO 
hours 23/29 79.3% 0/21 0% <0.001
Start mobilisation within 24 
PO hours 23/29 79.3% 0/21 0% <0.001
Start oral intake within 24 PO 
hours 23/29 79.3% 0/21 0% <0.001
Remove abdominal drains 2nd 
day PO 11/26 42.3% 1/21 4.76% 0.009
Remove IV therapy 2nd day PO 7/29 24% 0/21 0% <0.001
Remove urinary catheter 2nd 
day PO 23/29 79.3% 0/21 0% <0.001
CRP blood levels 3rd day 24/29 82.7% 5/21 23.8% <0.01
Table 4. Perioperative items (ERAS group vs CC group) and their compliance in the ERAS group.
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drain removal before 48 postoperative hours (ERAS 11/26 vs. CC 1/20), intravenous catheter removal on the 
second postoperative day (ERAS 7/29 vs. CC 0/21), urinary catheter removal on the second postoperative day 
(ERAS 23/29 vs. CC 0/21), and CRP levels on the third postoperative day (ERAS 24/29 vs. CC 5/21; p < 0.05) (see 
Table 4).
No significant differences were found for overall morbidity and mortality or for the readmission rate in either 
group, although a significantly reduced length of hospital stay was observed in the ERAS group (ERAS 7.7 ± 3.85 
vs. 10.9 ± 5.6 days; p = 0.009) (see Table 5).
Discussion
The results of implementing an ERAS programme in elective colon surgery showed a positive impact1–5, thus 
supporting the national model developed in Spain or the IMPRICA (Spanish ERAS National implementation 
project) using a multi-centre and interdisciplinary strategy6. Our current study is the first to report the results 
of patients treated with an ERAS protocol compared with those of a group of patients treated with conventional 
care following emergency colon surgery for left colon perforation according to the PSS classification. This study 
demonstrates that a specific ERAS protocol has a positive impact on patient outcomes, thereby accelerating 
patient recovery without compromising patient safety.
Few studies on the implementation of ERAS guidelines in emergency colon surgery are currently available. 
Verheijen et al.7 analysed the feasibility of ERAS in various patient groups based on the outcomes of 348 patients 
who underwent colon surgery and were managed using an ERAS programme, including 41 (12%) patients who 
underwent emergency surgery. The only significant differences after multivariate analysis were a decreased 
reoperation rate (8% vs. 26%) and reduced length of hospital stay (7 vs. 14 days) in the elective surgery group. 
Readmission and the anastomotic leak rate were similar in both groups. However, the study did not use a specific 
ERAS protocol and did not define the indications for emergency surgery.
Similarly, Loshiriwat et al.8 reported a comparative study of 20 patients with obstructive cancer colon who 
required emergency colectomy and were treated using an ERAS programme and 40 patients who were treated 
with conventional management. Roulin et al.9 reported another comparative study on the applicability of an 
ERAS programme in 28 patients (nine with colon perforation) after emergency colon surgery compared with 
63 patients who underwent elective colon surgery. ERAS programmes were found to be feasible in emergency 
surgery and did not increase morbidity or postoperative mortality in either study.
In 2017, a comparative study by Shida et al.10 included 122 consecutive patients undergoing emergency sur-
gery for obstructive colon neoplasia, 42 who were treated with conventional management and 80 who were 
treated using a modified ERAS programme. The results demonstrated reduced length of hospital stay, with no 
increase in postoperative morbidity or mortality.
A systematic review by Padararu et al.15 involved a search for ERAS protocols in emergency cases in the 
PubMed and Cochrane databases. These authors selected for analysis four cohort studies7–9,11, including three 
that were specific for emergency colon surgery7–9 and one by Wiseley et al.11 in which 370 patients undergoing 
emergency abdominal surgery and 151 patients (43%) undergoing colectomy (83 patients submitted to right 
colectomy, 21 to left colectomy and 53 to Hartmann’s intervention) were treated using ERAS protocols. In this 
latter paper, a fifth randomised study16 of patients undergoing emergency surgery for perforated duodenal ulcers 
was reported. Padararu15 concluded that the application of ERAS programmes to patients undergoing emergency 
gastrointestinal surgery improves their management without increasing morbidity or mortality.
Unlike the studies in the above-mentioned systematic review7–9,11, our study reported the results of a specific 
ERAS protocol for the management of patients undergoing emergency surgery of the same condition (perfora-
tion of the left colon) and aetiology (acute diverticulitis was the most frequent cause of perforation). In addition, 
all patients were homogeneous in terms of demographic data, surgical procedure and the severity of left colon 
perforation according to the Peritonitis Severity Score (PSS). Middle age, absence of aetiology of cancer-related 
perforation and a low to moderate risk of mortality according to the PSS are very important items for the selection 
of patients who are likely to benefit from an ERAS protocol.
Regarding the main endpoint of our study, in other words, impact of the new ERAS protocol on the post-
operative course at 90 days, the new management showed significantly lower morbidity rates (raw numbers 
and Clavien–Dindo classification)14, without adding cases of mortality or readmission. The ERAS group also 
Morbidity Clavien–
Dindo Classification
ERAS 
group 
(n = 29)
CC group 
(n = 21)
Statistical 
significance 
p < 0.05
• I 2 3 N/S
• II 0 1 N/S
• IIIa 3 2 N/S
• IIIb 1 1 N/S
• IVa 0 1 N/S
Overall morbidity 6 (20.7%) 8 (38%) N/S
Mortality 0 0 N/S
Readmissions 2 (6.8%) 1 (4.7%) N/S
Length hospital stay 7 (6-8) 9 (1-12) 0.009
Table 5. Postoperative morbidity/mortality, length hospital stay, readmissions.
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exhibited a significantly shorter length of postoperative hospital stay. These results are in accordance with previ-
ous systematic revision series15,17,18.
In general, ERAS guidelines for elective colon surgery include 21 items19; in our series, we tailored the elective 
ERAS items for colorectal surgery to twenty adapted items for patients with left colon perforation, as prior publi-
cations for emergency surgery did8,10.
In 2011 Gustafson et al.20 demonstrated that compliance is essential in the implementation of the elec-
tive ERAS protocol. Thus, compliance greater than 70% results in benefits for patients; in contrast, compli-
ance lower than 50% does not result in any benefit for patients. In the series by Loshiriwat18 with patients with 
intra-abdominal infection, compliance was 50%; in our series, global compliance was 62%, probably due to the 
patients being more homogeneous and selected. Regarding the different periods of the ERAS protocol, compli-
ance greater than 70% was observed in preoperative items 5 and 6 and in postoperative items 5 and 7; only intra-
operative items 2 and 7 showed compliance greater than 60%. In this last period, some issues must be considered. 
In this sense, the role of the laparoscopic approach in emergency colon surgery is debatable and must be carefully 
taken into consideration. Thus, Rea et al.21, in a study on emergency laparoscopic resection for acute diverticu-
litis in 67,645 patients, found the laparoscopic approach was successfully used only in 3.9% of the patients, with 
a 55% conversion rate. Furthermore, some studies on laparoscopic lavage and drainage of septic focus showed 
controversial results22,23. While two consensus documents24,25 state that laparoscopic lavage is not recommended 
in Hinchey IV, is safe in case of Hinchey III but it is not considered the preferred choice (Recommendation 
1 A). These same papers concluded that “laparoscopic sigmoid resection is feasible and safe in selected patients, 
hemodynamically stable, without significant comorbidities and with onset peritonitis <12-24 h, only in specific 
advanced laparoscopic colorectal expertise is available (Recommendation 2 C). Considering these recommenda-
tions and our results (with 13.7% compliance in laparoscopic colectomy and 10.3% in laparoscopic lavage and 
drainage of septic focus) we assume that the laparoscopic approach is not recommended as an ERAS item for 
emergency colon surgery.
Successful implementation of these recommendations is challenging based on their compliance due to existing 
barriers. Arroyo et al.26 observed that adherence to the protocol was greater in smaller and less complex hospitals, 
thus revealing a direct relationship with a shorter hospital stay. According to these results, we assume that the size 
of our hospitals and previous ERAS experience were essential during the implementation on emergency settings.
Our study has several limitations. First, the retrospective control group is subject to an inherent selection 
bias. However, it was not subject to selection and, ethically, we cannot currently consider a control group without 
enhanced recovery care. Secondly, this study has a relatively small sample size, since recruitment of this type of 
patients is not frequent. To the best of our knowledge, this is the first published study regarding the applicability 
of a specific ERAS protocol in the management of patients with left colon perforation requiring emergency colon 
surgery. This work can be used as a pilot study for future randomized studies.
In conclusion, the results of our study show that the implementation of ERAS guidelines in patients with 
peritonitis secondary to left colon perforation and in patients with a low to moderate risk of mortality according 
to the PSS is feasible and contributes to better management and patient outcomes. Previous experience with 
the management of elective surgical patients using these ERAS guidelines was essential to obtain these results. 
However, prospective and randomised studies are required to support and clarify these results.
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